| Norwich Endocrinology Llc | |
|
119 Sachem St Norwich CT 06360-4128 | |
| (860) 859-3006 | |
| (860) 859-1222 |
| Full Name | Norwich Endocrinology Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 119 Sachem St, Norwich, Connecticut |
| Authorized Official Name and Position | Constantin Carseli (OWNER) |
| Authorized Official Contact | 8608593006 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Norwich Endocrinology Llc 119 Sachem St Norwich CT 06360-4128 Ph: (860) 859-3006 | Norwich Endocrinology Llc 119 Sachem St Norwich CT 06360-4128 Ph: (860) 859-3006 |
| NPI Number | 1558418707 |
|---|---|
| Provider Enumeration Date | 01/03/2007 |
| Last Update Date | 03/07/2023 |
| Medicare PECOS PAC ID | 5395746457 |
|---|---|
| Medicare Enrollment ID | O20070117000037 |
News Archive
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to enable broader validation of an alternative approach to the Thorough QT (TQT) study.
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Today's health policy headlines include news about some little-known health reform provisions and how the Obama administration is using technology to help consumers navigate changes resulting from the health overhaul.
The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) are published online today in European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and on the ESC Website.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558418707 | NPI | - | NPPES |
| 11045496 | Other | CAQH NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 040484 (Connecticut) | Primary |
| Provider Name | Constantin Carseli |
|---|---|
| Provider Type | Practitioner - Endocrinology |
| Provider Identifiers | NPI Number: 1255428132 PECOS PAC ID: 3779584834 Enrollment ID: I20070117000028 |
News Archive
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to enable broader validation of an alternative approach to the Thorough QT (TQT) study.
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Today's health policy headlines include news about some little-known health reform provisions and how the Obama administration is using technology to help consumers navigate changes resulting from the health overhaul.
The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) are published online today in European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and on the ESC Website.
› Verified 3 days ago
News Archive
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to enable broader validation of an alternative approach to the Thorough QT (TQT) study.
Spirogen Limited and Celtic Therapeutics Holdings LP announced today the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is being sponsored by the National Cancer Institute of the USA, and is now actively recruiting patients for treatment.
Today's health policy headlines include news about some little-known health reform provisions and how the Obama administration is using technology to help consumers navigate changes resulting from the health overhaul.
The first European Society of Cardiology (ESC) Guidelines on Atrial Fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) are published online today in European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and on the ESC Website.
› Verified 3 days ago
Donna Civardi Rnfa, Aprn, Fnp-bc, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 18 Oneco St, Suite 2, Norwich, CT 06360 Phone: 860-383-2024 | |
Cll Health Care Clinic, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 527 W Thames St, Unit 23, Norwich, CT 06360 Phone: 203-271-7089 | |
Norwich Medical Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 12 Case St, Suite 103, Norwich, CT 06360 Phone: 860-889-4281 Fax: 860-887-7255 | |
Sang And Sridhar Digestive Disease Consultants Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 79 Wawecus St, Suite 102, Norwich, CT 06360 Phone: 860-859-9061 Fax: 860-889-6200 | |
Generations Family Health Center, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 330 Washington St, Ste 510, Norwich, CT 06360 Phone: 860-450-7471 | |
United Community And Family Services, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 47 Town Street, Norwich, CT 06360 Phone: 860-892-7042 Fax: 860-822-4939 |